San Diego-dependent Viking Therapeutics marked alone as a significant competitor within the weight loss drug marketplace in February right after revealing promising knowledge from a mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when specified like a weekly injection As well as in Marc